BSX
Boston Scientific Corporation
$42.97
▼ -0.51%
−$0.22
NYSE · Healthcare · Medical Devices
Boston Scientific Corporation
BSX · NYSE · Healthcare · Medical Devices
$42.97
▼ -0.51% · −$0.22 today
fundamentals72.8 /100 vs peers · 100% coverage
strong
5 of 5 metrics · 100% coverage
Revenue growth (TTM)17.4
24% above Sector 5Y avg avg · favorableSector 5Y avg: 14.1
EPS growth (TTM)74.4
551% above Sector 5Y avg avg · favorableSector 5Y avg: 11.4
EPS forecast (5Y)10.6
27% below Sector fwd avg avgSector fwd avg: 14.5
EPS next year10.6
solid pace
EPS growth (Q/Q)98.7
strong pace
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| BSXBoston Scientific Corporation | $63.87B | 18.1 | +17.4% | 73 |
| GMEDGlobus Medical | $10.45B | 17.9 | +23.5% | 78 |
| INDVIndivior | $4.94B | 20.5 | +10.3% | 78 |
| DXCMDexcom | $29.58B | 32.8 | +16.1% | 77 |
| LLYEli Lilly and Company | $1.11T | 42.4 | +47.4% | 76 |
